Neal Gould

Neal Gould is an accomplished scientist with extensive expertise in proteomics and drug development. Currently serving as the Proteomics Lab Leader and Principal Scientist at Denali Therapeutics since September 2022, Neal previously held positions as Principal Scientist and Senior Scientist at Tegmine Therapeutics, and as Senior Proteomics Scientist at Inzen Therapeutics, where Neal developed and expanded proteomics capabilities. Neal's research at The Children's Hospital of Philadelphia included significant work as an instructor and postdoctoral fellow, focusing on qualitative and quantitative proteomics to uncover disease targets, particularly in cancer and inflammation. Neal's earlier roles included research associate and graduate research assistant positions at National Jewish Health and the University of Pennsylvania, respectively. Neal holds a PhD in Toxicology from the University of Colorado Anschutz Medical Campus and a Bachelor of Science in Biology from Colorado State University.